Article
Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens.
British journal of cancer - 1 Apr 2023
Ishino Takamasa, Kawashima Shusuke, Tanji Etsuko, Ueno Toshihide, Ueda Youki, Ogasawara Sadahisa, Sato Kazuhito, Mano Hiroyuki, Ishihara Soichiro, Kato Naoya, Kawazu Masahito, Togashi Yosuke
Abstract excerpt
BACKGROUND: Identifying biomarkers to predict immune checkpoint inhibitor (ICI) efficacy is warranted. Considering that somatic mutation-derived neoantigens induce strong immune responses, patients with a high tumour mutational burden reportedly tend to respond to ICIs. However, there are several conflicting data. Therefore, we focused on the original function of neoantigenic mutations and their impact on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
